Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Glenmark Life Sciences Limited
EIR
•Glenmark Life Sciences Limited•July 5, 2019

Glenmark Life Sciences Limited – FDA EIR, Jul 5, 2019

Record Details

An FDA inspection was conducted at Glenmark Life Sciences Limited, located in Ankleshwar, India, from July 1 to July 5, 2019. This inspection, part of the CDER IOG Work-plan for FY19, focused on the company's compliance with Current Good Manufacturing Practices (cGMP) for Active Pharmaceutical Ingredients (API), adhering to Compliance Program 7356.002F and ICH Q7 guidelines. The inspection covered quality, production, facility, equipment, and laboratory systems. At the conclusion of the inspection, the FDA issued an FDA-483, detailing several significant observations. These included inadequate comprehensive investigations to determine the root cause of impurities, deficiencies in personnel training, incomplete batch record instructions, and insufficient control systems to prevent cross-contamination within the facility. The inspection resulted in a "Voluntary Action Indicated" (VAI) classification, meaning the FDA identified objectionable conditions that require corrective actions by the company, though immediate regulatory enforcement was not pursued. A routine re-inspection has been recommended to verify the implementation of these necessary improvements. This inspection followed a previous review in December 2016, which also received a VAI classification, with prior corrective actions deemed adequate.

Company
Glenmark Life Sciences Limited
Inspection date
July 5, 2019
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Saied A. Asbagh (Investigator)
  • Richmond K. Yip (issuing_officer)
View Company Profile

ID · bed8196b-01b9-48bd-a666-07cb979e7d5d

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Glenmark Life Sciences Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.